Aster DM Healthcare Ltd share price logo

Aster DM Healthcare Ltd (ASTERDM)

₹321.753.58%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Analyst Rating

based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts offering long term price targets for Aster DM Healthcare Ltd. An average target of ₹410.83

Source: S&P Global Market Intelligence

Aster DM Healthcare Ltd Share analysis

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹316.3
    ₹333
  • 52 Week's Low

    52 Week's High

    ₹294.35
    ₹558
1 Month Return-9.68 %
3 Month Return-37.32 %
1 Year Return+ 3.26 %
Previous Close₹333.70
Open₹333.00
Volume23.33L
Upper Circuit-
Lower Circuit-
Market Cap₹16,668.75Cr

Key Statistics

P/E Ratio123.75
PEG Ratio-20.83
Market Cap₹16,668.75 Cr
P/B Ratio4.38
EPS7.27

Mutual Fund Holdings

Funds HoldingsPrev. 6M
HDFC Small Cap Fund-Direct Growth OptionHDFC Small Cap Fund-Direct Growth Option2.37%
Nippon India Small Cap Fund - Direct Plan - Growth PlanNippon India Small Cap Fund - Direct Plan - Growth Plan0.59%
Franklin India Smaller Companies Fund Direct GrowthFranklin India Smaller Companies Fund Direct Growth2.09%
SBI Contra Fund Direct GrowthSBI Contra Fund Direct Growth0.83%
HDFC Childrens Gift Fund Direct Plan(Lock-in)HDFC Childrens Gift Fund Direct Plan(Lock-in)1.38%

Company Information

Aster DM Healthcare Ltd is a leading healthcare provider, incorporated in 1987. It is headquartered in Dubai, United Arab Emirates and operates in nine countries across the Middle East, India, and Philippines. The company is managed by Chairman Dr. Azad Moopen and CEO Dr. Harish Pillai.

Aster DM Healthcare Ltd is a multi-specialty healthcare provider with a wide range of services, including medical and surgical care, diagnostics, preventive care, fertility, and rehabilitation. In addition, the company provides medical education and training, and health insurance services.

Aster DM Healthcare Ltd offers a range of products, including medical equipment, pharmaceuticals, medical supplies, and health insurance. Its popular brands include Aster, Medcare, Access, and Prime. The company also operates several hospitals, clinics, and pharmacies, providing a range of medical services.

Share Price: ₹321.75 per share as on 19 Jul, 2024 04:01 PM
Market Capitalisation: ₹16,668.75Cr as of today
Revenue: ₹973.59Cr as on March 2024 (Q1 24)
Net Profit: ₹-2.17Cr as on March 2024 (Q1 24)
Listing date: 26 Feb, 2018
Chairperson Name: Mandayapurath Azad Moopen
OrganisationAster DM Healthcare Ltd
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

Key events for Aster DM Healthcare Ltd

  • Anonymous Complaints Against Aster DM Healthcare Employees - 16 Jul, 2024

    Aster DM Healthcare has received anonymous complaints against certain employees alleging unethical practices and professional misconduct. The company will initiate a forensic investigation.

  • Aster DM Healthcare Conducts Independent Review on Misconduct Allegations - 15 Jul, 2024

    Aster DM Healthcare is set to conduct an independent fact-finding review on allegations of misconduct by senior employees. The company has enlisted the services of Grant Thornton Bharat LLP following a complaint by an anonymous whistleblower. Additionally, Dr Azad Moopen expressed optimism about potential increase in healthcare funding.

  • PE Firm Acquires Majority Stake in Aster DM Healthcare's Middle-East Business - 05 Jul, 2024

    A consortium led by Fajr Capital, a sovereign-backed PE firm, has acquired a 65% stake in Aster GCC (Middle-East) for $907.6 million, with the Moopen family retaining a 35% stake and management rights. The family will continue to have a 41.8% stake in India operations and plans to invest ₹1,000 crore to expand its bed tally to over 6,600 in three years. Private equity firms are increasingly investing in Indian healthcare chains, providing capital for expansion.

  • Aster DM Healthcare's ROCE Declines to 5.3% - 23 Jun, 2024

    Aster DM Healthcare's return on capital employed (ROCE) has declined to 5.3%, lower than the industry average of 14%. The trend suggests that the company is not a growth stock, and its current liabilities have increased over the last five years.

  • Olympus Capital Asia Sells Stake in Aster DM Healthcare - 21 Jun, 2024

    Hong Kong-based Olympus Capital Asia has sold a 9% stake in Aster DM Healthcare for Rs 1530 crore through open market transactions, reducing its shareholding to 1.1%. Meanwhile, Franklin Templeton Mutual Fund, the Singapore government, and Morgan Stanley Asia Singapore purchased 1.24 crore shares of Aster DM Healthcare. Private equity firm Olympus Capital Asia also initiated a block trade, selling 9.3% equity worth Rs 1607 crore at Rs 345/share.

  • Olympus to Sell Stake in Aster DM Healthcare - 20 Jun, 2024

    Private equity firm Olympus is looking to sell a 5% stake in Aster DM Healthcare via a block deal of around $100 million, with an upsize option of an additional 5%. The floor price for the proposed trade is Rs 331/share, a 7.1% discount to the last closing price. Kotak Securities is acting as the advisor on the deal.

  • Aster DM Health Reports Decrease in Net Sales and Quarterly Net Loss - 18 Jun, 2024

    Aster DM Health's consolidated net sales for March 2024 decreased by 70.16% YoY, with a quarterly net loss of Rs. 24.03 crore. The stock has given -10.14% returns over the last 6 months and 19.61% over the last 12 months.

Insights on Aster DM Healthcare Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 11.91% to 13.25% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 9.60% to 10.59% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.11% to 13.59% in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 254.8% return, outperforming this stock by 153.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 41.88% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Global Health Ltd has given 69.4% return, outperforming this stock by 66.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 3.32K Cr → 977.67 Cr (in ₹), with an average decrease of 39.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ASTERDM stock has moved down by -37.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 179.21 Cr → -24.03 Cr (in ₹), with an average decrease of 113.4% per quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹973.59Cr
↑1.98%
Net Income
-₹2.17Cr
↓101.04%
Net Profit Margin
-0.22%
↓101.00%
2023Y/Y Change
Revenue
₹11,932.88Cr
↑16.38%
Net Income
₹475.49Cr
↓20.89%
Net Profit Margin
3.98%
↓32.08%
Value in ₹ crore
2023Y/Y Change
Total Assets
₹4,259.14Cr
↑8.13%
Total Liabilities
₹1,128.58Cr
↑14.72%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹245.86Cr
↑213.84%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
41.88%
0.00
Foreign Institutions
13.25%
0.00
Mutual Funds
13.59%
0.00
Retail Investors
10.59%
0.00
Others
20.68%
0.00

Key Indicators

Aster DM Healthcare Ltd Valuation

Aster DM Healthcare Ltd in the last 5 years

  • Overview

  • Trends

Lowest (11.94x)

March 24, 2020

Industry (90.76x)

July 19, 2024

Today (123.75x)

July 19, 2024

Highest (201.06x)

April 15, 2024

LowHigh

Earnings and Dividends

  • Aster DM Healthcare Ltd Earnings Results

    Aster DM Healthcare Ltd’s net profit fell -114.07% since last year same period to ₹-24.03Cr in the Q4 2023-2024. On a quarterly growth basis, Aster DM Healthcare Ltd has generated -113.41% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Aster DM Healthcare Ltd Dividends May,2024

    In the quarter ending March 2024, Aster DM Healthcare Ltd has declared dividend of ₹2 - translating a dividend yield of 37.30%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Aster DM Healthcare Ltd is currently in a Bearish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Aster DM Healthcare Ltd shares.

Aster DM Healthcare Ltd (ASTERDM) share price today is ₹321.75

Aster DM Healthcare Ltd is listed on NSE

Aster DM Healthcare Ltd is listed on BSE

  • Today’s highest price of Aster DM Healthcare Ltd is ₹333.
  • Today’s lowest price of Aster DM Healthcare Ltd is ₹316.3.

PE Ratio of Aster DM Healthcare Ltd is 123.75

PE ratio = Aster DM Healthcare Ltd Market price per share / Aster DM Healthcare Ltd Earnings per share

Today’s traded volume of Aster DM Healthcare Ltd(ASTERDM) is 23.33L.

Today’s market capitalisation of Aster DM Healthcare Ltd(ASTERDM) is ₹16668.75Cr.

Aster DM Healthcare Ltd(ASTERDMPrice
52 Week High
₹558
52 Week Low
₹294.35

Aster DM Healthcare Ltd(ASTERDM) share price is ₹321.75. It is down -42.34% from its 52 Week High price of ₹558

Aster DM Healthcare Ltd(ASTERDM) share price is ₹321.75. It is up 9.31% from its 52 Week Low price of ₹294.35

Aster DM Healthcare Ltd(ASTERDMReturns
1 Day Returns
-11.95%
1 Month Returns
-9.68%
3 Month Returns
-37.32%
1 Year Returns
3.26%